BIOMAT Database Logo BIOMAT Database Logo

[Clinical evaluation on S-6436 (author's transl)]. 1977

H Suzuki, and H Iwasaki, and S Ra, and K Matsumoto

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D002506 Cephalexin A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms. 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-,Cefalexin,Cephalexin Dihydride,Cephalexin Hemihydrate,Cephalexin Hydrochloride,Cephalexin Monohydrate,Cephalexin Monohydrochloride,Cephalexin Monohydrochloride, Monohydrate,Cephalexin, (6R-(6alpha,7alpha(R*)))-Isomer,Cephalexin, (6R-(6alpha,7beta(S*)))-Isomer,Cephalexin, (6R-(6alpha,7beta))-Isomer,Cephalexin, Monosodium Salt,Cephalexin, Monosodium Salt, (6R-(6alpha,7beta))-Isomer,Ceporexine,Palitrex
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014552 Urinary Tract Infections Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA. Infection, Urinary Tract,Infections, Urinary Tract,Tract Infection, Urinary,Tract Infections, Urinary,Urinary Tract Infection

Related Publications

H Suzuki, and H Iwasaki, and S Ra, and K Matsumoto
[Clinical studies on S-6436 (author's transl)].
June 1977, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
H Suzuki, and H Iwasaki, and S Ra, and K Matsumoto
[Fundamental and clinical studies on S-6436 (author's transl)].
July 1977, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
H Suzuki, and H Iwasaki, and S Ra, and K Matsumoto
[Long-acting cefalexin preparation (S-6436): pharmacokinetics and clinical evaluation (author's transl)].
June 1977, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
H Suzuki, and H Iwasaki, and S Ra, and K Matsumoto
[Clinical studies on S-6436 in urinary tract infections (author's transl)].
June 1977, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
H Suzuki, and H Iwasaki, and S Ra, and K Matsumoto
[Clinical evaluation of S-6436 in acute simple cystitis: A double blind comparative study of S-6436 and cephalexin (author's transl)].
June 1977, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
H Suzuki, and H Iwasaki, and S Ra, and K Matsumoto
[Clinical experience with S-6436 in acute pyelonephritis (author's transl)].
October 1977, The Japanese journal of antibiotics,
H Suzuki, and H Iwasaki, and S Ra, and K Matsumoto
[Clinical efficacy of S-6436 in urinary tract infection (author's transl)].
October 1977, The Japanese journal of antibiotics,
H Suzuki, and H Iwasaki, and S Ra, and K Matsumoto
[Clinical experience with S-6436 in urinary tract infections (author's transl)].
October 1977, The Japanese journal of antibiotics,
H Suzuki, and H Iwasaki, and S Ra, and K Matsumoto
[Pharmacological and clinical studies on S-6436 in urinary tract infections (author's transl)].
June 1977, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
H Suzuki, and H Iwasaki, and S Ra, and K Matsumoto
[Clinical studies on S-6436 in the urological and gynecological infections (author's transl)].
June 1977, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
Copied contents to your clipboard!